Literature DB >> 34200375

NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications.

Jagoda Siemaszko1, Aleksandra Marzec-Przyszlak2, Katarzyna Bogunia-Kubik1.   

Abstract

Natural Killer (NK) cells are natural cytotoxic, effector cells of the innate immune system. They can recognize transformed or infected cells. NK cells are armed with a set of activating and inhibitory receptors which are able to bind to their ligands on target cells. The right balance between expression and activation of those receptors is fundamental for the proper functionality of NK cells. One of the best known activating receptors is NKG2D, a member of the CD94/NKG2 family. Due to a specific NKG2D binding with its eight different ligands, which are overexpressed in transformed, infected and stressed cells, NK cells are able to recognize and attack their targets. The NKG2D receptor has an enormous significance in various, autoimmune diseases, viral and bacterial infections as well as for transplantation outcomes and complications. This review focuses on the NKG2D receptor, the mechanism of its action, clinical relevance of its gene polymorphisms and a potential application in various clinical settings.

Entities:  

Keywords:  NK cells; NKG2D ligands; NKG2D receptor

Year:  2021        PMID: 34200375     DOI: 10.3390/cells10061420

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  2 in total

1.  Deletion of the Natural Killer Cell Receptor NKG2C Encoding KLR2C Gene and Kidney Transplant Outcome.

Authors:  Hannes Vietzen; Bernd Döhler; Thuong Hien Tran; Caner Süsal; Philip F Halloran; Farsad Eskandary; Carsten T Herz; Katharina A Mayer; Nicolas Kozakowski; Markus Wahrmann; Sarah Ely; Susanne Haindl; Elisabeth Puchhammer-Stöckl; Georg A Böhmig
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

2.  Natural killer cells act as an extrinsic barrier for in vivo reprogramming.

Authors:  Elena Melendez; Dafni Chondronasiou; Lluc Mosteiro; Jaime Martínez de Villarreal; Marcos Fernández-Alfara; Cian J Lynch; Dirk Grimm; Francisco X Real; José Alcamí; Núria Climent; Federico Pietrocola; Manuel Serrano
Journal:  Development       Date:  2022-04-22       Impact factor: 6.862

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.